Brussels, 15/11/2012 (Agence Europe) - The EU is faced with an increasing number of new synthetic drugs that are difficult to identify and whose consumers are often unaware of their effects. This observation was made on Thursday 15 November by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in its annual report. The organisation warned that, “Europe is faced with an increasingly complex stimulant market, in which consumers are confronted with a wide variety of powders...